Aro Biotherapeutics Appoints Anthony Tolcher, MD, to Scientific Advisory Board

08:00 EDT 1 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Aro Biotherapeutics announced the appointment of Anthony Tolcher, MD, to its Scientific Advisory Board (SAB). Dr. Tolcher will provide strategic counsel on the development of novel Centyrin therapeutic candidates for oncology in...

Other Sources for this Article

Mike Beyer
Sam Brown Inc.


More From BioPortfolio on "Aro Biotherapeutics Appoints Anthony Tolcher, MD, to Scientific Advisory Board"

Quick Search

Relevant Topics

The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...